BSc Pharmacology and Innovative Therapeutics
UCAS code: B211
BSc (Hons) 3 years
Pharmacology is the study of medicines. Identified as a major skills deficit by pharmaceutical and biotechnology industries, this programme was designed in discussion with biopharmaceutical and research leaders to equip graduates to meet the shortfall, or to progress into academic careers or to apply for entry to training in medicine/dentistry.
Led by Barts and the London School of Medicine and Dentistry and co-taught by the School of Biological and Chemical Sciences, you will explore basic, molecular and clinical pharmacology, develop laboratory expertise, and understand the clinical trial and regulatory pathways bringing new drugs from ‘idea’ through to the patient.
- For more details, including how to apply, please visit the QMUL course finder
BSc MB BS
Our teaching commitments include basic pharmacology and clinical pharmacology across all five years of the school’s MB BS and BDS medical and dental undergraduate programmes.
Following GMC guidelines in Tomorrow’s Doctors, the undergraduate medical curriculum consists of a broadly integrated pattern of learning and assessment and contains a significant proportion of student-selected components. The Institute is meeting the challenge of supporting a vertically-integrated syllabus of pharmacology and therapeutics whilst maintaining the student’s basic science knowledge. We drive new initiatives for safe prescribing and preparing students for the forthcoming national prescribing skills assessment (UK-PSA).
- For more details including how to apply, please visit the School of Medicine and Dentistry
Graduate Entry Medicine GEP
Graduate Entry Medicine (GEP) and Graduate Entry MB BS Programme were instigated at Barts & The London in 2004. It was part of the first tranche of Graduate Entry Programmes developed by UK Medical Schools.
The unique component of the GEP is the first foundational year. Following this year, students are integrated into the 5-year course, starting the course at the beginning of the clinical year 3. The total length of the course is 4 years. The philosophy of the GEP is to tailor learning styles and content to the existing experience and maturity of the student.
The WHRI plays a major role in the organisation and teaching of the GEP programme. The programme is led by Dr Martin Carrier from the Centre for Translational Medicine and Therapeutics. All PBL tutors for the course come from the WHRI, as do all the mentors.
We are also responsible for organising the highly successful BMedSci and BSc intercalated degree programmes within the School of Medicine & Dentistry. The highest academically-ranked undergraduate medical students are given the opportunity to spend one year in an intensive research environment. In 2012 the WHRI allocated a total of 51 places on BMedSci courses in Molecular Medicine and Molecular Therapeutics and a BSc course in Sports & Exercise Medicine.
Members of the WHRI faculty also teach on courses organised by other institutes (for example the BSc intercalated degree in Experimental Pathology and School of Biological and Chemical Science courses in Forensic Science).